Eton Pharmaceuticals, Inc. ETON Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.55M— | —— | -$1.93M+25.5% | -$2.59M-64.4% | -$1.57M-163% | ||
| $1.13M+11.2% | $1.02M+0.8% | $1.01M+0.4% | $1.01M-0.8% | $1.01M+185% | ||
| $1.52M+35.1% | $1.12M+2.9% | $1.09M-47.9% | $2.1M+74.7% | $1.2M+53.5% | ||
| $1.65M— | —— | —— | —— | $11.04M+1,076% | ||
| -$1.41M-342% | $581K— | —— | $11.27M+3,247% | -$358K-144% | ||
| $2.51M— | —— | $2.12M-70.8% | $7.27M+930% | $705K-52.4% | ||
| -$1.53M-460% | $426K-76.1% | $1.79M+938% | $172K+113% | -$1.37M-167% | ||
| -$1.75M-170% | $2.52M— | —— | —— | -$2.97M-184% | ||
| -$7K— | —— | —— | —— | -$0— | ||
| $9K0.0% | $9K+80.0% | $5K-61.5% | $13K-23.5% | $17K-75.7% | ||
| $118K-32.6% | $175K-7.4% | $189K+294% | $48K-83.7% | $294K-71.7% | ||
| $7.41M— | —— | $12.03M+51.1% | $7.96M+281% | $2.09M— | ||
| $75K+53.1% | $49K-82.7% | $284K— | -$0— | -$0-100% | ||
| —— | -$0— | -$0— | -$0— | -$0-100% | ||
| $15M— | $0— | $0— | -$0— | -$0-100% | ||
| -$15.08M-30,665% | -$49K+82.7% | -$284K— | $0— | $0+100% | ||
| $1.39M+581% | $204K— | —— | —— | $394K-61.2% | ||
| $1.39M+230% | $421K— | —— | —— | $394K-98.8% | ||
| -$6.28M— | —— | $11.74M+47.5% | $7.96M+220% | $2.48M+147% | ||
| $881K-5.3% | $930K-39.7% | $1.54M+635% | $210K-67.3% | $642K+359% | ||
| $37K+3,600% | $1K-96.4% | $28K-65.4% | $81K+913% | $8K— | ||
| $118K-32.6% | $175K-7.4% | $189K+294% | $48K-83.7% | $294K-71.7% | ||
| $1.82M— | —— | —— | -$7.18M-228% | -$2.19M-5,666% | ||
| -$1.75M-170% | $2.52M— | —— | —— | -$2.97M-184% | ||
| $227K— | —— | —— | —— | $110K-16.8% | ||
| $9K0.0% | $9K+80.0% | $5K-61.5% | $13K-23.5% | $17K-75.7% | ||
| -$7K— | —— | —— | —— | -$0— | ||
| —— | -$0— | -$0— | -$0— | -$0-100% | ||
| $15M— | $0— | $0— | -$0— | -$0-100% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| $1.39M— | —— | —— | —— | $394K+447% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| $1.82M— | —— | $1.81M-45.1% | $3.29M-45.8% | $6.07M— | ||
| $350K-75.4% | $1.42M+7.3% | $1.32M+9.7% | $1.21M+5.7% | $1.14M— | ||
| $37K+3,600% | $1K-96.4% | $28K-65.4% | $81K+913% | $8K— | ||
| $7.33M— | —— | $11.74M+47.5% | $7.96M+281% | $2.09M— | ||
| $7.33M— | —— | $11.74M+47.5% | $7.96M+281% | $2.09M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Eton Pharmaceuticals, Inc. generate?
- Eton Pharmaceuticals, Inc. (ETON) generated $29.5M in operating cash flow over the trailing twelve months.
- What is Eton Pharmaceuticals, Inc.'s free cash flow?
- After $408.0K of capital expenditures, Eton Pharmaceuticals, Inc.'s free cash flow was $29.1M over the trailing twelve months, up 1588.2% year over year.
- Where does Eton Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Eton Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
